Ginger Wildheart has vowed to continue his concert commitments despite the diagnosis.
The Wildhearts have announced that frontman and founding member Ginger Wildheart has been diagnosed with Mantle Cell Lymphoma (MCL), a rare and aggressive form of cancer.
The news was shared in a statement posted to the band’s social media channels on Tuesday (16.03.26), revealing that the musician first began experiencing “severe pains” during the group’s UK headline tour last December.
According to the statement, Ginger pushed through the discomfort throughout the More Satanic Rites tour, taking painkillers so he could continue performing without disappointing fans.
After the run of shows, he sought medical tests to uncover the cause of the ongoing pain, and the diagnosis has now been confirmed.
The statement began: “During The Wildhearts’ incredible More Satanic Rites UK tour in December 2025, frontman and founding member Ginger Wildheart was experiencing severe pains that some nights forced him to take some short breaks from stage.
“Determined not to upset the band’s loyal fans – new and old – Ginger took painkillers to ensure the rock’n’roll was delivered, without missing a riff… We are saddened to report that Ginger has been diagnosed with Mantle Cell Lymphoma (MCL) – a rare but aggressive strain of cancer.”
Despite the diagnosis, the band said Ginger remains in “fine fettle” and is continuing to write new music.
All scheduled live commitments — including next month’s appearance at Takedown Festival — are still set to go ahead as planned.
The band have asked fans for support and positivity as Ginger begins the next stage of his treatment and recovery.
It continued: “While we process this news and await further medical advice, Ginger wants everyone to know that strength and positivity will prevail and the show will go on.
“Make sure you come and see The Wildhearts – sounding bigger and more refreshingly amazing than ever – at a venue near you soon.”
